I agree that this site is using cookies. You can find further informations here.
X
Hagelstein, Ilona
48  results:
Search for persons X
?
1

The bispecific B7H3xCD3 antibody CC-3 induces T cell immuni..:

Holzmayer, Samuel J. ; Liebel, Kai ; Hagelstein, Ilona..
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Induction of NK cell reactivity against acute myeloid leuke..:

Stefańczyk, Sylwia A. ; Hagelstein, Ilona ; Lutz, Martina S....
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Soluble NKG2DLs Are Elevated in Breast Cancer Patients and ..:

Seller, Anna ; Tegeler, Christian M. ; Mauermann, Jonas...
International Journal of Molecular Sciences.  25 (2024)  7 - p. 4126 , 2024
Link: https://doi.org/10.3390/..
 
?
4

An Fc-modified monoclonal antibody as novel treatment optio..:

Lutz, Martina S. ; Wang, Kevin ; Jung, Gundram..
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
5

Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 F..:

Kaidun, Polina ; Holzmayer, Samuel J. ; Greiner, Sarah M....
International Journal of Molecular Sciences.  24 (2023)  17 - p. 13156 , 2023
Link: https://doi.org/10.3390/..
 
?
6

An optimized IgG-based B7-H3xCD3 bispecific antibody for tr..:

Zekri, Latifa ; Lutz, Martina ; Prakash, Nisha...
Molecular Therapy.  31 (2023)  4 - p. 1033-1045 , 2023
Link: https://doi.org/10.1016/..
 
?
7

IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment..:

Hörner, Sebastian ; Moustafa-Oglou, Moustafa ; Teppert, Karin...
Cancers.  14 (2022)  16 - p. 3941 , 2022
Link: https://doi.org/10.3390/..
 
?
8

B7-H3-targeting Fc-optimized antibody for induction of NK c..:

Hagelstein, Ilona ; Engel, Monika ; Hinterleitner, Clemens...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
9

Identification of CD105 (endoglin) as novel risk marker in ..:

Greiner, Sarah M. ; Märklin, Melanie ; Holzmayer, Samuel...
Annals of Hematology.  101 (2022)  4 - p. 773-780 , 2022
Link: https://doi.org/10.1007/..
 
?
10

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Nove..:

Hagelstein, Ilona ; Lutz, Martina S. ; Schmidt, Moritz...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
11

CD18 Antibody Application Blocks Unwanted Off-Target T Cell..:

Kauer, Joseph ; Vogt, Fabian ; Hagelstein, Ilona...
Cancers.  13 (2021)  18 - p. 4596 , 2021
Link: https://doi.org/10.3390/..
 
?
12

CD105 (endoglin) as risk marker in AML patients undergoing ..:

Märklin, Melanie ; Hagelstein, Ilona ; Hinterleitner, Clemens...
International Journal of Hematology.  112 (2020)  1 - p. 57-64 , 2020
Link: https://doi.org/10.1007/..
 
?
13

An IgG‐based bispecific antibody for improved dual targetin..:

Zekri, Latifa ; Vogt, Fabian ; Osburg, Lukas...
EMBO Molecular Medicine.  13 (2020)  2 - p. , 2020
Link: https://doi.org/10.15252..
 
?
14

Identification of CD318 (CDCP1) as novel prognostic marker ..:

Heitmann, Jonas S. ; Hagelstein, Ilona ; Hinterleitner, Clemens...
Annals of Hematology.  99 (2020)  3 - p. 477-486 , 2020
Link: https://doi.org/10.1007/..
 
?
15

Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for ind..:

Märklin, Melanie ; Hagelstein, Ilona ; Koerner, Samuel P....
Journal for ImmunoTherapy of Cancer.  7 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
1-15